골형성 단백질 시장 : 유형별, 용도별, 최종사용자별, 지역별

Global bone morphogenetic protein market is estimated to be valued at USD 342.3 Mn in 2024 and is expected to reach USD 444.5 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 3.8% from 2024 to 2031.

Figure. Bone Morphogenetic Protein Market Share (%), By Region 2024

Global bone morphogenetic protein market has been witnessing notable growth in the past few years, owing to increasing prevalence of orthopedic diseases and rising number of spinal fusion surgeries. Bone morphogenetic proteins (BMPs) belong to the transforming growth factor-B (TGF-B) superfamily. BMPs play an important role in bone formation and regulate osteoblast differentiation and matrix mineralization. They have been approved for use in spinal fusion and long bone fracture healing. Various clinical and preclinical studies investigating their effectiveness and safety have demonstrated their potential to induce new bone formation. With rising awareness regarding their benefits and commercial availability of these novel biologics, the bone morphogenetic protein market is expected to experience significant growth over the forecast period.

Market Dynamics:

The primary growth drivers for the global bone morphogenetic protein market include rising geriatric population and subsequent increase in orthopedic surgeries and diseases, increasing prevalence of spinal disorders, lack of alternative treatment options, and commercial availability and adoption of bone morphogenetic proteins. However, shortcomings related to safety concerns over BMP use and high costs are expected to restrain the market growth. Ongoing research and development activities focusing on developing safer and affordable BMP formulations is expected to create lucrative opportunities for market players over the next few years.

Key Features of the Study:

This report provides in-depth analysis of the global bone morphogenetic protein market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global bone morphogenetic protein market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Medtronic, Stryker, DePuy Synthes, NuVasive, Orthofix Holdings, Smith & Nephew, Thermo Fisher Scientific, R&D Systems, Ember Therapeutics, Sigma Aldrich Co., Cellumed Co. Ltd., ProSpec, Wright Medical Group N.V., Amedica Corporation, and Bioventus

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global bone morphogenetic protein market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global bone morphogenetic protein market

Market Segmentation

• By Type Insights (Revenue, USD Mn, 2019 - 2031)
  • Recombinant Bone Morphogenetic Proteins (rhBMPs)
  • Synthetic Bone Morphogenetic Proteins
  • Natural Bone Morphogenetic Proteins
• By Application Insights (Revenue, USD Mn, 2019 - 2031)
  • Orthopedic Surgeries
  • Dental Surgeries
  • Spinal Surgeries
  • Craniofacial Surgeries
  • Other Applications
• By End User Insights (Revenue, USD Mn, 2019 - 2031)
  • Hospitals
  • Ambulatory Surgical Centers
  • Research Institutions
  • Others
• Regional Insights (Revenue, USD Mn, 2019 - 2031)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • Medtronic
  • Stryker
  • DePuy Synthes
  • NuVasive
  • Orthofix Holdings
  • Smith & Nephew
  • Thermo Fisher Scientific
  • R&D Systems
  • Ember Therapeutics
  • Sigma Aldrich Co.
  • Cellumed Co. Ltd.
  • ProSpec
  • Wright Medical Group N.V.
  • Amedica Corporation
  • Bioventus

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Bone Morphogenetic Protein Market, By Type
  • Global Bone Morphogenetic Protein Market, By Application
  • Global Bone Morphogenetic Protein Market, By End User
  • Global Bone Morphogenetic Protein Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Driver
  • Restraint
  • Opportunity
• Impact Analysis
• Key Developments
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario
• Industry Trends

4. Global Bone Morphogenetic Protein Market, By Type, 2019-2031, (USD Mn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Recombinant Bone Morphogenetic Proteins (rhBMPs)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
• Synthetic Bone Morphogenetic Proteins
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
• Natural Bone Morphogenetic Proteins
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

5. Global Bone Morphogenetic Protein Market, By Application, 2019-2031, (USD Mn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Orthopedic Surgeries
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
• Dental Surgeries
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
• Spinal Surgeries
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
• Craniofacial Surgeries
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
• Other Applications
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

6. Global Bone Morphogenetic Protein Market, By End User, 2019-2031, (USD Mn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
• Ambulatory Surgical Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
• Research Institutions
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

7. Global Bone Morphogenetic Protein Market, By Region, 2019 - 2031, Value (USD Mn)

• Introduction
  • Market Share (%) Analysis, 2024,2027 & 2031, Value (USD Mn)
  • Market Y-o-Y Growth Analysis (%), 2020 - 2031, Value (USD Mn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Type, 2019 - 2031, Value (USD Mn)
  • Market Size and Forecast, By Application, 2019 - 2031, Value (USD Mn)
  • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Mn)
  • Market Size and Forecast, By Country 2019 - 2031, Value (USD Mn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Type, 2019 - 2031, Value (USD Mn)
  • Market Size and Forecast, By Application, 2019 - 2031, Value (USD Mn)
  • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Mn)
  • Market Size and Forecast, By Country 2019 - 2031, Value (USD Mn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Type, 2019 - 2031, Value (USD Mn)
  • Market Size and Forecast, By Application, 2019 - 2031, Value (USD Mn)
  • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Mn)
  • Market Size and Forecast, By Country 2019 - 2031, Value (USD Mn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Type, 2019 - 2031, Value (USD Mn)
  • Market Size and Forecast, By Application, 2019 - 2031, Value (USD Mn)
  • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Mn)
  • Market Size and Forecast, By Country 2019 - 2031, Value (USD Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Type, 2019 - 2031, Value (USD Mn)
  • Market Size and Forecast, By Application, 2019 - 2031, Value (USD Mn)
  • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Mn)
  • Market Size and Forecast, By Country 2019 - 2031, Value (USD Mn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Type, 2019 - 2031, Value (USD Mn)
  • Market Size and Forecast, By Application, 2019 - 2031, Value (USD Mn)
  • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Mn)
  • Market Size and Forecast, By Country/Region, 2019 - 2031, Value (USD Mn)
    • South Africa
    • North Africa
    • Central Africa

8. Competitive Landscape

• Medtronic
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Stryker
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• DePuy Synthes
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• NuVasive
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Orthofix Holdings
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Smith & Nephew
• Thermo Fisher Scientific
• R&D Systems
• Ember Therapeutics
• Sigma Aldrich Co.
• Cellumed Co. Ltd.
• ProSpec
• Wright Medical Group N.V.
• Amedica Corporation
• Bioventus

9. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

10. References and Research Methodology

• References
• Research Methodology
• About us